MBXBF (Microbix Biosystems) Net Issuance of Debt : $-0.38 Mil (TTM As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Microbix Biosystems Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. Microbix Biosystems's net issuance of debt for the three months ended in Dec. 2024 was $-0.05 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.38 Mil.

Microbix Biosystems Net Issuance of Debt Historical Data

The historical data trend for Microbix Biosystems's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbix Biosystems Net Issuance of Debt Chart

Microbix Biosystems Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Net Issuance of Debt

Get a 7-Day Free Trial

-1.02

0.07

-1.04

0.92

-0.39

Microbix Biosystems Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Net Issuance of Debt	Get a 7-Day Free Trial															-0.05	-0.05	-0.22	-0.05	-0.05

Microbix Biosystems Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.38 Mil.

Microbix Biosystems Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Microbix Biosystems's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Microbix Biosystems Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (OTCPK:MBXBF) » Definitions » Net Issuance of Debt

Comparable Companies

Traded in Other Exchanges

MBX:Canada

Address

265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3

Website

https://www.microbix.com

Microbix Biosystems Inc develops biological products and technologies. There are two operating segments: The development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and; Development and commercialization of novel and proprietary products or technologies such as Kinlytic. Geographically, it derives a majority of revenue from North America and also operates in Europe and other foreign countries.